国药控股(01099.HK)今日盘中股价大涨7.29%,截至10时07分,报价为19.72港元。市场分析认为,国药控股最新一期财报数据表现亮眼,成为推升股价的主因。
最新财报显示,国药控股实现营业收入3229.25亿港元,同比大增20.9%,净利润40.58亿港元,同比增长10.5%。公司每股收益1.30港元,市盈率仅6.16倍,估值水平较低。 毛利增长至240.43亿港元。
作为国内领先的医药流通企业,国药控股营收和利润的持续增长,反映了业务发展态势良好,吸引投资者追捧,推动股价大涨。不过,针对后市表现,市场观点仍不统一,期待公司后续发展提供更多利好支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.